HARVEY CAPITAL MANAGEMENT INC
Q1 2014 13F-HR Holdings
Net value change ($000)
+8,626
(3.6%)
New positions
7
Sold out positions
10
Turnover %
12.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GE | 7,279 | 262.3% |
| GOODRICH PETROLEUM CORP | 7,234 | NEW |
| TIME WARNER INC | 4,118 | 1267.1% |
| KERYX BIOPHARMACEUTICALS | 4,074 | 35.3% |
| PHARMACYCLICS INC | 3,316 | NEW |
| MAGNUM HUNTER RES CORP DEL | 2,477 | 20.4% |
| CHGG | 2,070 | NEW |
| NVAX | 1,883 | 455.9% |
| HALO | 1,773 | 55.3% |
| PORTOLA PHARMACEUTICALS INC | 1,652 | 147.9% |
Top Reduces (Value $000, Stocks/ETFs)
| NPS PHARMACEUTICALS INC | -3,985 | -23.9% |
| SM | -3,854 | -87.8% |
| CARRIZO OIL & GAS INC | -3,135 | -62.4% |
| VOD | -2,963 | -100.0% |
| CELG | -2,694 | -23.5% |
| INTERCEPT PHARMACEUTICALS, INC. | -2,631 | -100.0% |
| EOG | -2,534 | -52.4% |
| XOMA | -2,470 | -97.6% |
| MJC | -2,387 | -100.0% |
| IBM | -2,157 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|